골수이형성증후군 환자의 한약을 사용한 치험 1례
One Case of Myelodysplastic Syndrome Treated with Herbal Medicine
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objectives: The aim of this study was to identify the effects of herbal medicine on the clinical symptoms and abnormal blood tests of a patient with myelodysplastic syndrome. Methods: A 64-year-old woman diagnosed with myelodysplastic syndrome in 2020 was prescribed Bojungikgi-tang-gagambang from January 6, 2022 to June 22, 2022 to reduce bleeding tendency and frequent defecation and to improve laboratory findings, such as platelet count. We observed changes in the symptoms and improvement of laboratory findings after six months of treatment. Results: In this study, approximately six months of treatment with Bojungikgi-tang-gagambang showed considerable improvement in laboratory findings and clinical symptoms, especially frequent defecation, petechiae, and gum bleeding, compared to the baseline parameters of the first visit. Also, no adverse effects, such as liver injury or decreased kidney function, were observed during herbal medicine treatment. Conclusion: This study suggests the availability of herbal medicine as a therapeutic option for managing patients with myelodysplastic syndrome.
Abstract
Objectives: The aim of this study was to identify the effects of herbal medicine on the clinical symptoms and abnormal blood tests of a patient with myelodysplastic syndrome. Methods: A 64-year-old woman diagnosed with myelodysplastic syndrome in 2020 was prescribed Bojungikgi-tang-gagambang from January 6, 2022 to June 22, 2022 to reduce bleeding tendency and frequent defecation and to improve laboratory findings, such as platelet count. We observed changes in the symptoms and improvement of laboratory findings after six months of treatment. Results: In this study, approximately six months of treatment with Bojungikgi-tang-gagambang showed considerable improvement in laboratory findings and clinical symptoms, especially frequent defecation, petechiae, and gum bleeding, compared to the baseline parameters of the first visit. Also, no adverse effects, such as liver injury or decreased kidney function, were observed during herbal medicine treatment. Conclusion: This study suggests the availability of herbal medicine as a therapeutic option for managing patients with myelodysplastic syndrome.
참고문헌 (19)
- Cazzola M, "Myelodysplastic Syndromes", New England Journal of Medicine, 383(14), pp.1358~1374 (2020)
- Arber DA, "The 2016revision to the World Health Organization classification of myeloid neoplasms and acute leukemia", Blood, 127(20), pp.2391~2405 (2016)
- Annual report of cancer statistics in Korea in 2018, "Korea Central Cancer Registry", Ministry of Health and Welfare, ~ (2020)
- Cheong JW, "Myelodysplastic Syndrome", Journal of the Korean Medical Association, 49(10), pp.897~907 (2006)
- 정준원, "골수형성이상증후군에서의 임상진료지침", Blood Research, 42(2), pp.1~1 (2007), 대한혈액학회
- Saber W, "Transplantation for myelodysplastic syndromes : who, when, and which conditioning regimens", Hematology, 2016(1), pp.478~484 (2016)
- Kim JD, "A case of myelodysplastic syndrome", Journal of Internal Korean Medicine, 20(1), pp.274~279 (1999)
- 김준영, "Well-Managed Myelodysplastic Syndrome Patients Treated with Traditional Korean Medicine; Report of Two Cases", 대한한방내과학회지, 37(3), pp.539~547 (2016), 대한한방내과학회
- 주성희, "요통을 동반한 MDS 환자에 대한 관리 1례", 대한한방내과학회지, 39(2), pp.230~236 (2018), 대한한방내과학회
- Duetz C, "The wider perspective : twenty years of clinical trials in myelodysplastic syndromes", British Journal of Haematology, 196(2), pp.329~335 (2022)
- Adès L, "Myelodysplastic syndromes", The Lancet, 383(9936), pp.2239~2252 (2014)
- Jonas BA, "MDS prognostic scoring systems-Past, present, and future", Best Practice & Research Clinical Haematology, 28(1), pp.3~13 (2015)
- Giagounidis A, "Current treatment algorithm for the management of lower-risk MDS", Hematology, 2017(1), pp.453~459 (2017)
- Ramos F, "Myelodysplastic Syndrome : Riding the Crest of the Wave", Journal of Clinical Medicine, 11(6), pp.1616~ (2022)
- Germing U, "Myelodysplastic syndromes : diagnosis, prognosis, and treatment", Dtsch Arztebl Int, 110(46), pp.783~790 (2013)
- Oliva EN, "Quality of life and physicians'perception in myelodysplastic syndromes", American Journal of Blood Research, 2(2), pp.136~147 (2012)
- Vicente A, "Eltrombopag monotherapy can improve hematopoiesis in patients with low to intermediate risk-1myelodysplastic syndrome", Haematologica, 105(12), pp.2785~2794 (2020)
- 강혜인, "보중익기탕(補中益氣湯) 추출물의 대식세포 분화 유도 효과", 한국식품영양과학회지, 34(3), pp.330~335 (2005), 한국식품영양과학회
- Jun JH, "Effects of Korean Traditional Medicine on Murine Hematopoiesis", The Journal of Internal Korean Medicine, 22(3), pp.156~168 (2001)